MICROORC’s Post

𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗔𝗻𝗶𝗺𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗪𝗼𝗿𝗸𝘀𝘁𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟯-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report encompasses a comprehensive overview of the Laboratory Animal Research Workstation industry chain, evaluating the market status of Scientific Research (Class II Type A, Class II Type B) and Veterinary Hospitals and Clinics (Class II Type A, Class II Type B), while identifying key enterprises in both developed and developing markets. It delves into an analysis of cutting-edge technology, patents, popular applications, and market trends within the Laboratory Animal Research Workstation domain. Regionally, North America and Europe are witnessing consistent growth propelled by government initiatives and heightened consumer awareness. Meanwhile, Asia-Pacific, especially China, stands at the forefront of the global Laboratory Animal Research Workstation market, driven by substantial domestic demand, supportive policies, and a robust manufacturing base. The report aims to present a comprehensive understanding of the Laboratory Animal Research Workstation market, offering a holistic perspective of the industry, detailed insights into various components and stakeholders, and an analysis of market dynamics, trends, challenges, and opportunities within this sector. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗙𝘂𝘁𝘂𝗿𝗲 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗔𝗻𝗶𝗺𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗪𝗼𝗿𝗸𝘀𝘁𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dFDfqE-q *𝗕𝘆 𝗧𝘆𝗽𝗲: Class II Type A, Class II Type B, Class III *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Scientific Research, Veterinary Hospitals and Clinics, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Sychem Ltd, Labconco Corporation, Nuaire, Allentown, LLC, Hallowell, Mopec, Thermo Fisher Scientific, faster srl, Kewaunee Scientific Corp., biobase, Azbil Telstar #LabAnimalResearch #ResearchWorkstations #AnimalResearch #LabEquipment #ScientificResearch #VeterinaryResearch #ResearchTechnology #LabWorkstations #BioscienceResearch #AnimalResearchLab

Today, we showcase the third and fourth African startups among the 20 selected participants for the AIT Swiss-Africa Annual Conference hosted in Lagos. These startups specialise in biotechnology, specifically focusing on animal and human health. There has never been a more critical time to emphasize the interconnectedness of human and animal health, encapsulated within the framework of One Health. Switzerland has taken a significant step in fostering collaboration among public health, animal health, agriculture, and the environment through the establishment of the One Health interdisciplinary platform. By supporting African innovations such as veterinary vaccine development by Iraka Biotech and rapid diagnostics for infectious diseases in humans by Igagasi Biotech, Switzerland underscores its dedication to contributing to the tools that facilitate realising One Health objectives. #onehealth #biotechnology Department of Science and InnovationTechnology Innovation Agency Swissnex Innocircle Innosuisse

Today, Caroline Chauché, our Head of Scientific Output and Veterinary Education at MI:RNA is attending the #BioFIT2023 meeting in Marseille. The meeting started with an insightful session on "Adding value to early-stage innovation through partnering: What are the working models and how to valorise the partnership" A couple of excellent points were raised by the panel, like "Be creative in your working model" and "Show agility and capability", and always "Stay open minded and accept unexpected partners". It's important for a startup like MI:RNA to "stay focused on the right objective, and fuel the right pipeline that fill real market gaps". The last one that we particularly agree with is to "Always consider your investor as partners, choose them right, and protect your IP". This resonates well with us, and we have paid attention to "bring on-board the right people with the right experience", as we have done with Dr. Judy Jarecki-Black, our IP and Legal advisor.  https://lnkd.in/eZmwXmcd #diagnostics #animalhealth #veterinaryprofessionals #startupstory #AI #innovation #biotechnology #research #testing #biomarkers #artificialintelligence #precisionmedicine #investment #womenintech #womeninstem 

Win Win: @Dr. Sophie Kittler of Veterinary University Hannover spent 4 days at Klifovet GmbH, part of the Argenta Group, to exchange scientific, regulatory and quality know-how on novel therapies within her translational medicines CE. The team of #klifovet, led by Dr. Cornelia Hüttinger and Dr. Klaus Hellmann benefited especially on Sophie’s extended scientific know-how on bacteriophage based technologies and her experiences with using #bacteriophages in #poultry, while the #klifovet team helped Sophie to get a better feeling of the regulatory pathways to market and related quality requirements in the current #animalhealth EU legal framework. A true win/ win for all, within the #OneHealth concept. Thanks to all involved. Mode of action:

The 4th edition of the #Entomology Summer Course will be held at the Ecole Nationale Vétérinaire de Toulouse, France from the 8th to the 12th of July 2024. Deadline for applications: 30.04.2024 – Only a few places left!   Since its creation in 2019, the course has gathered approximately 50 participants from more than 20 countries worldwide and 20 internationally renowned speakers. This one-week course adopts a “global approach” by covering vector-borne diseases of both humans and animals in temperate and tropical areas, resistance in arthropod populations, control tools, principles of laboratory rearing, and morphological identification of arthropods of medical and veterinary importance. This course is a balanced blend of lectures, field and laboratory work and of course social events!   The scholarship “Young Scientist Award” instituted at the initiative of Vincenzo Lorusso and still supported by the veterinary pharmaceutical multinational firm Vetoquinol Global, in collaboration with the French Society of #Parasitology, aims to support the participation of an outstanding PhD student from a Low- and Middle-Income Country (#LMIC) to foster continuous education in medical and veterinary entomology also in the developing world. So far 4 students were supported coming from #Tunisia, #Morocco, #Ghana and #Nigeria. Please make sure you get your application together and apply soon!! See you hopefully in #Toulouse in July?! 👉 Application here: entomologysummercourse.com With an immense thanks to: Dr. Katrin Blazejak Norbert Mencke Frédéric Beugnet Marie Varloud Bettina Schunack Thomas Geurden Alain Mondon Céline Hubinois Vetoquinol Global Boehringer Ingelheim Ceva Santé Animale Elanco Zoetis MSD Virbac ESCCAP (European Scientific Counsel Companion Animal Parasites) #SummerCourse #GlobalHealth #PublicHealth #OneHealth #PlanetaryHealth #NTDs #NeglectedTropicalDiseases #Parasitology #Insects #Parasites #Vectors #ContinuingEducation #EVPC

# Cell4pharma's Commitment to Reducing Animal Experimentation in Medical Research Exciting news for the medical research community as the Dutch government makes a significant investment of €124.5 million in the transition to animal-free innovation. This investment signifies a pivotal moment towards more ethical and advanced methods in the field. At Cell4pharma, we have always been at the forefront of innovation, and this aligns perfectly with our mission to substantially reduce the use of animal experimentation in medical research. We believe that cutting-edge technology and innovative approaches can lead us to groundbreaking discoveries without the need for animal testing. The Dutch government's initiative reinforces our commitment to finding alternative methods that are not only more humane but also more accurate and efficient. This investment will drive the research landscape towards a future where animal testing is minimized, and scientific progress is propelled by cutting-edge technologies. We are proud to be part of this transformative journey and look forward to contributing our expertise and passion to the collective mission of advancing medical research while respecting animal welfare. Join us in this progressive movement towards a more sustainable and ethical future in the field of pharmaceutical research. Read more about the Dutch National Growth Fund's investment [here](https://lnkd.in/eXYAGAED). #AnimalFreeInnovation #MedicalResearch #Cell4pharma #Innovation #EthicalResearch

👏 Our talented PhD student, Maria Høgh Kroier (Aarhus University, Department of Animal and Veterinary Sciences), has created a new illustration for the PIG-PARADIGM project, highlighting the impressive cohort study within the Host Pillar. 🐽 The foundation for this pillar is a comprehensive clinical and pathological characterization of #intestinal health in a cohort of 2,500 pigs with the aim to differentiate unequivocally between the phenotype of the robust pig and the non-robust pig. The overarching scientific focus is to elucidate the complex interactions between the intestinal #microbiome and host factors and determine their separate and combined influence on intestinal health and resilience. ✨ To learn more about the research in Host Pillar, check out the information here 👉 https://lnkd.in/dT5GFZh5 Merete Fredholm Jens Peter Nielsen

#PetIndustry Alert: Mars Incorporated's strategic acquisition of SYNLAB Laboratory Services Vet signals a transformative shift in the global petcare sector. 🌍 Mars deepens its footprint in pet diagnostics and technology. 🌍 Enhanced R&D firepower, broadened diagnostic solutions, and an enriched service ecosystem. Investor Insights: Diversification in petcare, tech-driven opportunities, and alignment with global pet wellbeing trends. Read More: https://lnkd.in/gdTGJKu3 Stay ahead in this fast-paced market. Connect with Market Unwinded for more in-depth insights. #Mars #SYNLABVet #MarketUnwinded #PetcareInnovation

Yesterday my colleagues #LiesbetDendas, #ThomasHerget and I had the opportunity to attend the European Partnership for Alternative Approaches to Animal Testing (#EPAA) Annual Conference 2023 in Brussels. While we as #MerckGroup already committed to phase out animal usage in our businesses, it was good to hear from EPAA panelists of ECHA, PETA, CEFIC, European Commission and Academia that they also see general alignment on the progress being made to increase acceptance of alternatives and support the development of an EU roadmap. We expect more details on this after a workshop hosted by the European Commission in early December. It was agreed that scientific evidence for alternatives alone is not enough, and regulatory hurdles also need to be taken, which are a key focus for EPAA, which has over its 18-year history managed to move the needle on lowering regulatory hurdles and improving cross-regional cooperation. Consensus was clear on the current political momentum we have reached, with a renewed focus on the use of #NewApproachMethodologies (NAMs) in regulatory processes for chemicals and the EU has a definitive interest in remaining a leader pushing for a global application of NAMs. The commitment on animal-free is not enough but implementation and acceptance of NAMs is key. Therefore, we as Merck enhance the use of NAMs and our teams like to offer their expertise and ownership in alternatives like the Monocyte-Activation-Test (PyroMAT™) for replacing the obsolete Rabbit Pyrogen Test (RPT). This correlates well with #KirstyReid’s statement from EFPIA, that the Pharma Industry is not leaning back and waiting for roadmaps but even already is on a road trip with phasing-in NAMs. Full transparency on this transition journey and a collaborative approach is supportive. EPAA enables us to actively contribute to a strong stakeholder community of broadly like-minded organizations actively working to improve lab animal welfare and, for Merck, the implementation of the 4Rs. We need to apply AI to impactfully use our existing knowledge and here coordination of work is important to avoid working in silos, which includes all stakeholders from industry to commission. If all efforts are put in this, especially the regulatory work, I am confident that we get closer to the ultimate goal. #AnimalWelfare #AnimalTesting #merckgroup #3Rs #EPAA #EFPIA #PyroMAT #AlternativesToAnimalTesting

So, what is it like being a CEO and Founder of a dynamic startup in the veterinary diagnostics field? This week Eve has been busy attending conferences, giving presentations, networking, building relationships, and promoting MI:RNA. Check out this video for a sneak peek into the life of a busy CEO. #diagnostics #animalhealth #veterinaryprofessionals #startupstory #Technology #AI #innovation #biotechnology #research #testing #biomarkers #artificialintelligence #precisionmedicine #investment #womenintech #womeninstem #ceomindset #ceolife #ceoinsights